
VolitionRx Limited
AMEX:VNRX
Overview | Financials
Company Name | VolitionRx Limited |
Symbol | VNRX |
Currency | USD |
Price | 0.748 |
Market Cap | 58,438,214 |
Dividend Yield | 0% |
52-week-range | 0.58 - 2.74 |
Industry | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Cameron Reynolds MBA |
Website | https://www.volition.com |
An error occurred while fetching data.
About VolitionRx Limited
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD